Viewing Study NCT00003732


Ignite Creation Date: 2025-12-24 @ 9:28 PM
Ignite Modification Date: 2026-01-01 @ 8:24 PM
Study NCT ID: NCT00003732
Status: COMPLETED
Last Update Posted: 2013-08-12
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer
Sponsor: Rigshospitalet, Denmark
Organization:

Organization Data

Organization:
Class: NIH
Study ID: DAN-104864/373
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators